Menu

Benzyl Alcohol

Also known as: Phenylmethanol, Benzenemethanol

A cosmetic preservative and fragrance ingredient; a specific 5% drug lotion has separate head-lice evidence.

Two-tone linocut of an unlabelled amber vial and a clear droplet in a glass dish
Editorial illustration

Benzyl alcohol is used in cosmetics as a preservative and fragrance ingredient. Separately, FDA approved a particular 5% benzyl alcohol lotion for head lice in patients aged six months and older. That drug evidence does not turn a moisturizer containing benzyl alcohol into a lice treatment. Irritation and contact allergy remain possible.1, 2

  • Benzyl alcohol and benzyl benzoate are different compounds.1
  • The 2020 FDA label concerns 5% lotion for head lice, not everyday skincare.2
  • That lotion does not kill lice eggs; its labeled regimen includes a second application.2

What is Benzyl Alcohol?

Benzyl alcohol is an aromatic alcohol, not ethanol and not benzyl benzoate. It can occur in plant-derived aromatic materials, while cosmetic supplies may also be manufactured. Natural origin does not determine allergy risk. Its purpose and exposure should be read from the finished product, rather than inferred from the word alcohol alone.1

Where it comes from

Natural sources

  • Occurs in some botanical fragrance materials

How it's made

Commercial benzyl alcohol can be manufactured and purified for cosmetic or pharmaceutical specifications.

What it does in products

  • Cosmetic preservation and fragrance
  • Active ingredient in a specified prescription head-lice lotion

Benefits

Preservation of a cosmetic formula

limited evidence

Preservation serves the product. Finding benzyl alcohol on a label is not evidence of an additional anti-aging or skin-healing benefit.1

The CIR assessment addresses cosmetic functions and safety of reported exposures; it is not a trial of complexion improvement.

Head-lice treatment in a specific drug formulation

moderate evidence

Vehicle-controlled clinical studies support the particular 5% lotion described in the FDA label.3, 2

The trial program and label apply to a defined lotion, age group and repeat-treatment regimen. They do not support raw benzyl alcohol or an unrelated cosmetic as a substitute.

Evidence scope and limitations

Cosmetic benzyl alcohol and the historical FDA-labeled 5% head-lice lotion, treated as different uses and exposures.

  • The drug trials cannot be generalized to a cosmetic or a different concentration.
  • The 2020 prescribing information is cited for evidence context, not confirmation of current brand availability.
  • CIR assesses reported cosmetic use, not a guarantee that a sensitive individual will tolerate a product.

Evidence last checked: 2026-10-07

Side effects & safety

Irritation and contact dermatitis (varies)The drug label reports application-site effects and warns about eye contact. Cosmetic tolerance is also formula-specific.

Safety considerations

  • The drug label's pregnancy and lactation discussion does not establish safety of arbitrary raw-material exposure; use the relevant product information and clinical advice.
  • Do not extrapolate compatibility of cosmetic or drug combinations from a trial of the lotion alone.
  • Not for: Known benzyl-alcohol contact allergy is relevant to cosmetic selection.
  • Not for: The labeled drug is not for infants younger than six months; the label includes neonatal toxicity warnings.
  • Not for: Do not ingest the lotion or use it in the eyes; children require the supervision described by the label.
2, 1, 4

Amounts studied & product use

These figures describe research or common product use, not a personal dose or treatment recommendation.

In skincare studies and products

There is no consumer DIY concentration recommended here. For historical clinical context, the FDA's 2020 label describes a 5% scalp/hair lotion with two 10-minute applications seven days apart. This is a drug regimen, not an instruction to add benzyl alcohol to skincare; current treatment choice and product availability require separate checking.

2, 1

Regulatory status

  • Cosmetic use does not constitute FDA approval. FDA initially approved the specified 5% head-lice lotion in 2009; this guide cites its 2020 label without asserting current brand availability.
  • INCI name on cosmetic labels: Benzyl Alcohol.
  • The published 2017 group assessment supports the practices of use and concentrations it describes, and supersedes its 2001 conclusion.
1, 2, 5

One molecule, two different evidence questions

In a cosmetic, the question is whether the preservation system and exposure are appropriate for that formula. In the head-lice trials, the question was whether a defined medicinal lotion cleared an infestation. Those endpoints should not share a generic 'benefits' claim.

Our reading: neither 'contains alcohol' nor 'plant-derived' settles whether a person will tolerate a product. A known allergy and a particular product's directions are more actionable than the ingredient's marketing category.

1, 3, 2, 4

Frequently asked questions

Does a cosmetic with benzyl alcohol kill head lice?

The cited evidence concerns a specified 5% drug lotion, not cosmetics containing a small preservative amount. A cosmetic label cannot establish the drug's concentration, vehicle or treatment results.3, 2

Is every alcohol in skincare the same?

No. Benzyl alcohol is a distinct compound. Its name alone cannot establish the tolerability of a whole formula, and CIR's group conclusion is not a promise of zero irritation.1, 4

The bottom line

Keep cosmetic preservation, personal allergy and a specific drug indication separate. Do not convert a label ingredient into a home lice treatment.

References

  1. Johnson W Jr, Bergfeld WF, Belsito DV, et al.. Safety Assessment of Benzyl Alcohol, Benzoic Acid and its Salts, and Benzyl Benzoate. International Journal of Toxicology (2017) · safety assessment · PMID 29243541; DOI 10.1177/1091581817728996
  2. ULESFIA (benzyl alcohol) lotion, 5%: Prescribing Information. U.S. Food and Drug Administration (2020) · government guidance · NDA 022129; 2020 label
  3. Meinking TL, Villar ME, Vicaria M, et al.. The clinical trials supporting benzyl alcohol lotion 5% (Ulesfia): a safe and effective topical treatment for head lice (pediculosis humanus capitis). Pediatric Dermatology (2010) · randomized trial · PMID 20199404; DOI 10.1111/j.1525-1470.2009.01059.x
  4. Allergens in Cosmetics. U.S. Food and Drug Administration · government guidance · Undated resource; accessed October 7, 2026
  5. FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated. U.S. Food and Drug Administration (2013) · government guidance

Revision history

  1. Initial AI-assisted source compilation with claim-level citations, formulation distinctions and explicit evidence limitations; not independent medical review.